絞り込み

16763

広告

「"Goudemand J "[Author]」の検索結果

193件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Hemostatic profile of infants with spontaneous prematurity: can we predict intraventricular hemorrhage development?

Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra ): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP).

Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.

Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence.

FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders.

Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional study.

The common single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance.

Fifth Åland Island conference on von Willebrand disease.

Analyses of the FranceCoag cohort support immunogenicity differences among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.

New findings on inhibitor development: from registries to clinical studies.

Summary report of the First International Conference on inhibitors in haemophilia A.

Key insights to understand the immunogenicity of FVIII products.

Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.

Characterization of a novel large deletion caused by double-stranded breaks in 6-bp microhomologous sequences of intron 11 and 12 of the F13A1 gene.

A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.

A novel ELISA-based diagnosis of acquired VWD with increased VWF proteolysis.

Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study.

Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
Sort by
※並べ替えは表示に時間がかかります